Venturelab
close

Body friendly implants for soft tissue repair

Regenosca SA

Swiss Startup - Regenosca Profile Main Image
Incorporated
10.01.2019
Headquarters
Lausanne
Support

Regenosca provides regenerative medicine technology that enables permanent regrowth of your own native tissues on a self-absorbing mesh, ensuring seamless healing of soft tissue defects and surgical wounds. Our solutions are cost-effective, safe, and designed with surgeons in mind.
TissueSpan is an innovative, natural mesh, designed to support seamless soft tissue repair and function as a protective barrier. While not a living tissue, it is engineered to actively attract and organize the patient’s own cells upon implantation, initiating the body’s natural regenerative processes. Fully absorbable, off-the-shelf, and ready-to-use, TissueSpan ensures easy clinical translation and compatibility with current surgical techniques.

Milestones news

15.10.2023

All patients of First-in-Man study operated

10.05.2023

All patients of First-in-Man study operated

01.04.2023

KOL is joining First-in-Man study as investigator

10.01.2023

Closing of Seed Round

04.10.2022

Closing of convertible loan with private investors

30.08.2022

First patients operated in a First-in-Man study

30.08.2022

First patients operated in a First-in-Man study

10.04.2022

Closing of convertible loan with private investors

08.03.2022

Regenosca's patent is granted in the US

08.03.2022

Regenosca's patent is granted in the US

28.04.2021

Regenosca's patent is granted in Europe

Show all
Swiss Startup - Regenosca Product Image Swiss Startup - Regenosca Team Image Swiss Startup - Regenosca Additional Image